the chemotherapeutic agent 5- ( 3,3-dimethyl-1-triazeno ) -imidazole-4-carboxamide ( dtic ) is used in the treatment of malignant melanoma where response rates of 15 to 30 % have been reported .
C0010927
dtic
C0025202
response